The landscape of clinical trial reimbursement continues to evolve, presenting both opportunities and challenges for healthcare organizations, medical device companies, and research institutions. Our recent expert panel brought together industry leaders to address the critical questions surrounding commercial payer perspectives on clinical trial reimbursement.
Featured Panelists
Carla Monacelli – Partner at JD Lymon
Dr. Chuck Stemple – former Medical Director of Humana and Consulting Medical Director at JDL Access
Kim Norton (Moderator) – CEO of JDL Access
Joe Popowicz – Founder and CEO Emergent CRO
Key Discussion Points
Commercial Payer Evaluation Process
Our panelists explored how commercial payers approach clinical trial reimbursement decisions, including the criteria they use to evaluate coverage and the internal processes that guide their determinations.
Managing Early Claims Exposure
A critical concern for many organizations is whether early claims visibility might trigger unwanted payer policy reviews. The panel addressed strategies for managing this risk while maintaining transparency with payers.
Pricing Strategy Implications
The relationship between clinical trial pricing and future commercial pricing presents a complex challenge. Our experts discussed how decisions made during the trial phase can significantly impact long-term commercial viability and payer relationships.
Operational Best Practices
Practical considerations covered include:
- Establishing effective communication protocols with payers
- Notifying payers about expected claims from trial sites
- Understanding billing requirements and ID number protocols
- Site-level responsibilities and compliance considerations
Why This Matters
For healthcare professionals involved in clinical research, understanding payer perspectives is essential for successful trial execution and future commercial success. This discussion provides actionable insights based on real-world experience from industry veterans.
Target Audience
This content is particularly valuable for:
- Clinical research professionals
- Healthcare reimbursement specialists
- Medical device and pharmaceutical companies
- Healthcare policy professionals
- Clinical trial site administrators
- Healthcare executives involved in innovation strategies